ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 3044

Endothelin 1 Induces a Myofibroblastic Phenotype in Vascular Smooth Muscle Cells. A Mechanism Potentially Contributing to Vascular Remodeling and Intimal Hyperplasia in Giant Cell Arteritis

Ester Planas-Rigol1, Nekane Terrades-Garcia2, Marc Corbera-Bellalta2, Ester Lozano2, Marco Antonio Alba2, Georgina Espígol-Frigolé3, Sergio Prieto-González2, Marta Segarra2, Jose Hernández-Rodríguez2, Sara Preciado4, Rodolfo Lavilla4 and Maria C. Cid2, 1Vasculitis research unit. Department of Autoimmune Diseases, Hospital Clínic. University of Barcelona. IDIBAPS, Barcelona, Spain, 2Vasculitis Research Unit. Department of Autoimmune Diseases, Hospital Clínic. University of Barcelona. IDIBAPS, Barcelona, Spain, 3Vasculitis Research Unit, Systemic Autoimmune Diseases, Hospital Clínic. University of Barcelona. IDIBAPS, Barcelona, Spain, 4Laboratory of Organic Chemistry, Faculty of Pharmacy. Barcelona Science Park, Barcelona, Spain

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: Cell Migration, giant cell arteritis, Inflammation, intima medial thickness and vasculitis

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Vasculitis III: Pathogenic Mechanisms

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Giant cell arteritis (GCA) is a vascular inflammatory disease involving large and medium sized arteries, particularly the cranial vessels. Inflammation-induced vascular remodeling leads to vascular occlusion and ischemic symptoms and complications including partial or complete visual loss and, in some cases, stroke or other symptoms of vascular insufficiency. Pathogenic mechanisms contributing to this process are incompletely understood although vascular smooth muscle cell (VSMC) acquisition of a myofibroblastic phenotype might be involved. Over-expression of endothelin-1 (ET-1) and its receptors ETAR and ETBR in GCA lesions as well as increased serum concentrations of ET-1 in patients with ischemic complications has been previously reported (Lozano E et al Ann Rheum Dis 2010). The most investigated function of ET-1 in VSMC is vascular tone regulation. In recent years, it has been shown that ET-1 may contribute to myofibroblast differentiation of fibroblasts, a crucial step in lung and skin fibrogenic diseases. Whether ET-1 has similar effects on VSMC contributing to vascular occlusion has not been investigated. The aim of this study is to investigate if ET-1 induces a migratory myofibroblastic phenotype in human temporal artery (TA) -derived VSMC which might contribute to vascular remodeling and ischemic complications.

Methods: Ex vivo culture of TAs into three-dimensional matrix, migration assays using primary cultures of TA-derived VSMC, co-culture of TA-derived VSMC with peripheral blood mononuclear cells. Immunofluorescence and confocal microscopy of TA, qRT-PCR, immunoassay and western-blot.

Results: In GCA lesions ET-1 was mainly produced by inflammatory cells whereas VSMC overexpressed ET-1 receptors which enhanced their ability to respond to ET-1. ET-1 promoted a spread morphology in cultured VSMC and stimulated their migration by inducing focal adhesion kinase (FAK) phosphorylation at Y397 permitting the association with p85 subunit of PI3Kinase which co-localized with FAK at the cell protrusions of migrating cells. Accordingly, inhibition of both FAK and PI3K abrogated ET-1 induced migration. Interestingly, ET-1 treatment of cultured non pathological TAs promoted the disorganization of the artery layers as a consequence of VSMC migration towards the intima layer. Consistently, blockade of ETAR and ETBR with BQ123 and BQ788 antagonists inhibited ET-1 induced VSMC migration and VSMC outgrowth from cultured GCA-arteries as well as reduced Y397FAK phosphorylation in vitro and ex vivo.

Conclusion: ET-1 may be involved in GCA vascular occlusion by promoting VSMC migration towards the intimal layer, a mechanism involving either ETAR or ETBR. Suported by SAF 2014/57708-R, PIE 13/00033 and FEDER.


Disclosure: E. Planas-Rigol, None; N. Terrades-Garcia, None; M. Corbera-Bellalta, None; E. Lozano, None; M. A. Alba, None; G. Espígol-Frigolé, None; S. Prieto-González, None; M. Segarra, None; J. Hernández-Rodríguez, None; S. Preciado, None; R. Lavilla, None; M. C. Cid, None.

To cite this abstract in AMA style:

Planas-Rigol E, Terrades-Garcia N, Corbera-Bellalta M, Lozano E, Alba MA, Espígol-Frigolé G, Prieto-González S, Segarra M, Hernández-Rodríguez J, Preciado S, Lavilla R, Cid MC. Endothelin 1 Induces a Myofibroblastic Phenotype in Vascular Smooth Muscle Cells. A Mechanism Potentially Contributing to Vascular Remodeling and Intimal Hyperplasia in Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/endothelin-1-induces-a-myofibroblastic-phenotype-in-vascular-smooth-muscle-cells-a-mechanism-potentially-contributing-to-vascular-remodeling-and-intimal-hyperplasia-in-giant-cell-arteritis/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2016

ACR Meeting Abstracts - https://acrabstracts.org/abstract/endothelin-1-induces-a-myofibroblastic-phenotype-in-vascular-smooth-muscle-cells-a-mechanism-potentially-contributing-to-vascular-remodeling-and-intimal-hyperplasia-in-giant-cell-arteritis/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology